1. Home
  2. TCRX vs SND Comparison

TCRX vs SND Comparison

Compare TCRX & SND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRX
  • SND
  • Stock Information
  • Founded
  • TCRX 2018
  • SND 2011
  • Country
  • TCRX United States
  • SND United States
  • Employees
  • TCRX N/A
  • SND N/A
  • Industry
  • TCRX Biotechnology: Pharmaceutical Preparations
  • SND Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • TCRX Health Care
  • SND Industrials
  • Exchange
  • TCRX Nasdaq
  • SND Nasdaq
  • Market Cap
  • TCRX 67.9M
  • SND 75.4M
  • IPO Year
  • TCRX 2021
  • SND 2016
  • Fundamental
  • Price
  • TCRX $1.44
  • SND $2.06
  • Analyst Decision
  • TCRX Strong Buy
  • SND Hold
  • Analyst Count
  • TCRX 6
  • SND 2
  • Target Price
  • TCRX $9.83
  • SND $2.63
  • AVG Volume (30 Days)
  • TCRX 520.8K
  • SND 282.5K
  • Earning Date
  • TCRX 05-12-2025
  • SND 05-12-2025
  • Dividend Yield
  • TCRX N/A
  • SND 4.87%
  • EPS Growth
  • TCRX N/A
  • SND N/A
  • EPS
  • TCRX N/A
  • SND 0.08
  • Revenue
  • TCRX $2,816,000.00
  • SND $311,372,000.00
  • Revenue This Year
  • TCRX $47.30
  • SND N/A
  • Revenue Next Year
  • TCRX $74.30
  • SND N/A
  • P/E Ratio
  • TCRX N/A
  • SND $26.72
  • Revenue Growth
  • TCRX N/A
  • SND 5.20
  • 52 Week Low
  • TCRX $1.02
  • SND $1.73
  • 52 Week High
  • TCRX $9.69
  • SND $2.80
  • Technical
  • Relative Strength Index (RSI)
  • TCRX 49.74
  • SND 44.52
  • Support Level
  • TCRX $1.02
  • SND $1.80
  • Resistance Level
  • TCRX $1.36
  • SND $2.11
  • Average True Range (ATR)
  • TCRX 0.16
  • SND 0.20
  • MACD
  • TCRX 0.05
  • SND -0.03
  • Stochastic Oscillator
  • TCRX 77.78
  • SND 31.71

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About SND Smart Sand Inc.

Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.

Share on Social Networks: